Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Analysts made bold calls this week. Three separate firms raised price targets on AVGO on the same day — a rare show of force.
Rosenblatt led the charge. Analyst Sajal Dogra lifted his target to $600, up from $500. BMO Capital followed, raising to $575 from $455. Cantor Fitzgerald matched Rosenblatt at $600. All three kept Buy ratings. Broadcom's market cap now sits at $1.75 trillion. Short interest is just 1.2% of free float — shorts are firmly on the sidelines.
The opposite happened at MRNA. Rothschild & Co downgraded the vaccine maker to Sell. Analyst Simon Baker slashed his target to $40 from $81 — a 51% cut. Short interest already stands at 13.5% of free float. Shares have plenty of room to fall if he's right.
California utilities also took a hit. PCG was downgraded by consensus. The average target dropped to $19.91. EIX and both saw target price cuts too. A sector-wide reassessment appears underway.
FDX bucked the trend. Analysts raised the delivery giant's consensus target to $356. The stock carries just two sell ratings against 20 holds.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
